Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Pharmacyclics Inc (PCYC)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 73,583,000
Market Cap: N/A
Last Volume: 1,917,000 Avg Vol: 912,944
52 Week Range: $259.55 - $259.55
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:

    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile  


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 344
  Page 10 of 14  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Hamdy Ahmed Md Chief Medical Officer   •       –      –    2010-10-05 4 AS $8.20 $123,000 D/D (15,000) 2,010     -
   Hamdy Ahmed Md Chief Medical Officer   •       –      –    2010-10-05 4 OE $0.73 $10,950 D/D 15,000 17,010     -
   Buggy Joseph J VP, Research   •       –      –    2010-10-01 4 AS $8.01 $373,669 D/D (46,630) 6,000     -
   Buggy Joseph J VP, Research   •       –      –    2010-10-01 4 OE $0.86 $65,512 D/D 46,630 21,000     -
   Duggan Robert W Chairman and CEO   •       •       •   2010-06-21 4 B $6.51 $6,999,995 D/D 1,075,268 10,904,702 3.23     -
   Rice Glenn C Director   –       •      –    2010-02-12 4 OE $0.91 $182,000 D/D 200,000 605,944     -
   Duggan Robert W Chairman and CEO   •       •       •   2010-01-22 4 D $0.00 $0 I/I (33,500) 602,714     -
   Bamdad Cynthia Director   –       •      –    2010-01-20 4 S $4.16 $20,574 D/D (4,950) 0     -
   Bamdad Cynthia Director   –       •      –    2010-01-20 4 OE $1.94 $9,603 D/D 4,950 4,950     -
   Bamdad Cynthia Director   –       •      –    2010-01-19 4 S $4.22 $27,830 D/D (6,600) 0     -
   Bamdad Cynthia Director   –       •      –    2010-01-19 4 OE $1.31 $11,203 D/D 6,600 4,058     -
   Bamdad Cynthia Director   –       •      –    2010-01-14 4 S $4.16 $317,887 D/D (76,329) 0     -
   Bamdad Cynthia Director   –       •      –    2010-01-14 4 OE $0.81 $72,508 D/D 76,329 76,329     -
   Adelman Jason T Director   –       •      –    2009-12-31 4 OE $1.24 $31,500 D/D 25,403 25,403     -
   Van Den Broek Richard Director   –       •      –    2009-12-17 3 IO $0.00 $0 I/I 0 138,730     -
   Duggan Robert W Chairman and CEO   •       •       •   2009-12-17 4 D $0.00 $0 I/I (12,900) 636,214     -
   Buggy Joseph J VP, Research   •       –      –    2009-10-30 4 A $1.66 $1,658 D/D 1,000 6,000     -
   Loury David J Vice President of Development   •       –      –    2009-10-30 4 A $1.06 $1,063 D/D 1,000 1,000     -
   Hamdy Ahmed Md Chief Medical Officer   •       –      –    2009-10-30 4 A $1.06 $1,063 D/D 1,000 1,000     -
   Rice Glenn C President and COO   •       •      –    2009-10-30 4 A $1.06 $1,063 D/D 1,000 405,944     -
   Erdtmann Rainer M VP of Finance   •       –      –    2009-10-30 4 A $1.06 $1,063 D/D 1,000 1,000     -
   Smith David Duane Director   –       •      –    2009-08-05 4 OE $1.28 $408 D/D 319 2,000     -
   Rice Glenn C President and COO   •       •      –    2009-08-05 4 OE $1.28 $400,000 D/D 312,500 404,944     -
   Duggan Robert W Chairman and CEO   •       •       •   2009-07-31 4 OE $1.28 $170,691 I/I 133,352 649,112     -
   Duggan Robert W Chairman and CEO   •       •       •   2009-07-31 4 OE $1.28 $6,086,234 D/D 4,754,870 9,829,434     -

  344 Records found
  Previous  10  11  12  13  14   
  Page 10 of 14
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed